Status:
COMPLETED
Registrar Performances in MIDP
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Minimally Invasive Distal Pancreatectomy
Eligibility:
All Genders
18-99 years
Brief Summary
This study aimed to determine whether registrar involvement in minimally invasive distal pancreatectomy (MIDP) was associated with adverse outcomes.
Detailed Description
From January 2009 to March 2020, data of all consecutive patients requiring distal pancreatectomy in our public tertiary hospital were prospectively collected and retrospectively analyzed. Registrars...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology between 2009-2020
- Exclusion criteria:
- open distal pancreatectomy
- minimally invasive distal pancreatectomy for pancreatic cancer
- 20 first consecutive patients operated on by the consultant (learning curve)
Exclusion
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT04429074
Start Date
December 1 2019
End Date
June 1 2020
Last Update
June 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295